SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Abbott Says TECTONIC Trial Shows Strong 30-Day Outcomes

Abbott reported strong 30-day outcomes and high procedural success in its TECTONIC clinical trial of the investigational SonicForce coronary intravascular lithotripsy system.

ABT

Story updates

08:45:40 PM UTC
SquawkNews
SonicForce de Abbott logra éxito en el 97% de los procedimientos en ensayo clínico TECTONIC Abbo
08:45:44 PM UTC
SquawkNews
Dispositivo SonicForce da Abbott atinge sucesso em 97% dos procedimentos em ensaio clínico A Abb

Related stories